<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:p="urn:schemas-microsoft-com:office:powerpoint" xmlns:a="urn:schemas-microsoft-com:office:access" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:s="uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs="urn:schemas-microsoft-com:rowset" xmlns:z="#RowsetSchema" xmlns:b="urn:schemas-microsoft-com:office:publisher" xmlns:ss="urn:schemas-microsoft-com:office:spreadsheet" xmlns:c="urn:schemas-microsoft-com:office:component:spreadsheet" xmlns:odc="urn:schemas-microsoft-com:office:odc" xmlns:oa="urn:schemas-microsoft-com:office:activation" xmlns:html="http://www.w3.org/TR/REC-html40" xmlns:q="http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc="http://microsoft.com/officenet/conferencing" xmlns:D="DAV:" xmlns:Repl="http://schemas.microsoft.com/repl/" xmlns:mt="http://schemas.microsoft.com/sharepoint/soap/meetings/" xmlns:x2="http://schemas.microsoft.com/office/excel/2003/xml" xmlns:ppda="http://www.passport.com/NameSpace.xsd" xmlns:ois="http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns:dir="http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds="http://www.w3.org/2000/09/xmldsig#" xmlns:dsp="http://schemas.microsoft.com/sharepoint/dsp" xmlns:udc="http://schemas.microsoft.com/data/udc" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:sub="http://schemas.microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec="http://www.w3.org/2001/04/xmlenc#" xmlns:sp="http://schemas.microsoft.com/sharepoint/" xmlns:sps="http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:udcs="http://schemas.microsoft.com/data/udc/soap" xmlns:udcxf="http://schemas.microsoft.com/data/udc/xmlfile" xmlns:udcp2p="http://schemas.microsoft.com/data/udc/parttopart" xmlns:wf="http://schemas.microsoft.com/sharepoint/soap/workflow/" xmlns:dsss="http://schemas.microsoft.com/office/2006/digsig-setup" xmlns:dssi="http://schemas.microsoft.com/office/2006/digsig" xmlns:mdssi="http://schemas.openxmlformats.org/package/2006/digital-signature" xmlns:mver="http://schemas.openxmlformats.org/markup-compatibility/2006" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:mrels="http://schemas.openxmlformats.org/package/2006/relationships" xmlns:spwp="http://microsoft.com/sharepoint/webpartpages" xmlns:ex12t="http://schemas.microsoft.com/exchange/services/2006/types" xmlns:ex12m="http://schemas.microsoft.com/exchange/services/2006/messages" xmlns:pptsl="http://schemas.microsoft.com/sharepoint/soap/SlideLibrary/" xmlns:spsl="http://microsoft.com/webservices/SharePointPortalServer/PublishedLinksService" xmlns:Z="urn:schemas-microsoft-com:" xmlns:st="&#1;" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 12 (filtered medium)">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:"Monotype Corsiva";
        panose-1:3 1 1 1 1 2 1 1 1 1;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p
        {mso-style-priority:99;
        margin:0in;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {mso-style-priority:34;
        margin-top:0in;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:.5in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
span.emailstyle17
        {mso-style-name:emailstyle17;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
span.EmailStyle19
        {mso-style-type:personal;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
span.EmailStyle21
        {mso-style-type:personal-reply;
        font-family:"Calibri","sans-serif";
        color:#1F497D;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page Section1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.Section1
        {page:Section1;}
 /* List Definitions */
 @list l0
        {mso-list-id:1274485171;
        mso-list-type:hybrid;
        mso-list-template-ids:637017184 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
        {mso-level-number-format:bullet;
        mso-level-text:;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Symbol;}
ol
        {margin-bottom:0in;}
ul
        {margin-bottom:0in;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1" />
 </o:shapelayout></xml><![endif]-->
</head>

<body bgcolor=white lang=EN-US link=blue vlink=purple id=compText>

<div class=Section1>

<p class=MsoNormal><span style='color:#1F497D'>I’m going to continue the
dialogue with the hopes that we’re not cluttering your inboxes.  I would have
loved to have all of this information a few years back, so I’m hopeful it is
helping somebody out there.  <o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>You’re right – it is virtually
impossible to have a take-back event without collecting controlled substances. 
If you tell the public “don’t bring controlled substances”, the average person
has no idea what that means.  Also, one of the earlier emails seemed to imply
that anything not over-the-counter is a controlled substance.  I may have
misread it, but that certainly is not true.  There are OTC meds, non-controlled
prescriptions, and controlled substance prescriptions.  <o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>From our perspective, it is
necessary to include controlled substances in take-back events.  These are your
OxyContin, Vicodin, Lortab – some might recognize the C-I, C-II, C-III
nomenclature.  As I am from a poison center, these are some of the most
dangerous substances out there in terms of poisonings.  These can result in
respiratory depression and death.  (Others can as well.)  As one of our goals
is to prevent poisonings, we feel it important to include controls.  Controlled
substances are also highly abused – particularly by teens who participate in “pharming”
(raiding of medicine cabinets for prescription drugs.)  Prevention of abuse is
another goal of our take-back events.  The stats on abuse are astounding:  <o:p></o:p></span></p>

<p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;color:#1F497D'><span style='mso-list:Ignore'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='color:#1F497D'>62% of teens report
prescription pain relievers are easy to get from parents’ medicine cabinets
(2005 Partnership Attitude Tracking Study)<o:p></o:p></span></p>

<p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;color:#1F497D'><span style='mso-list:Ignore'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='color:#1F497D'>Prescription drug
abuse is second only to marijuana use (2007 National Survey on Drug Use and
Health)<o:p></o:p></span></p>

<p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;color:#1F497D'><span style='mso-list:Ignore'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='color:#1F497D'>Each day 2,500 teens
use a prescription medication for the first time for a non-medical reason
(Prescription for Danger: A Report on the Troubling Trend of Prescription and
Over-the-Counter Drug Use Among the Nation’s Teens, 2008; Office of National
Drug Control Policy, Executive Office of the President)<o:p></o:p></span></p>

<p class=MsoListParagraph style='text-indent:-.25in;mso-list:l0 level1 lfo1'><![if !supportLists]><span
style='font-family:Symbol;color:#1F497D'><span style='mso-list:Ignore'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='color:#1F497D'>There are now more
people aged 12 and up who use psychotherapeutic drugs for non-medical reasons
than those who abuse cocaine, heroin, and methamphetamine combined (2007
National Survey on Drug Use and Health)<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>When we began collaborating with
our local law enforcement to participate in our events, we had drafted a letter
for them to send to the DEA to obtain “authorization” for the collection of
controlled substances.  DEA National Headquarters had stated that a letter
would be needed, that it should come from the participating law enforcement agency,
that it should detail the steps taken to prevent diversion, should state that
LE will witness the burn of the controls, etc.  We were told by our regional
DEA office (Dallas) yesterday that the requirement for a letter of
authorization from DEA is at the discretion of the regional Special Agent in
Charge (SAC).  Our does not require a request for authorization as long as law
enforcement is involved and they handle the drugs in accordance with their
local policy.  <o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>The difficult thing about the
DEA is that they are not consistent (case in point – regional SAC has
discretion to determine need for letter of authorization) and they generally
will not provide anything in writing unless it is through the Federal
Register.   (On a personal level, I do not like the idea of participating in
something that could result in criminal prosecution, not to mention the loss of
my license, based on someone’s word-- i.e “You don’t need a letter of
authorization from us.”)  Work is currently being done to amend the Controlled
Substances Act to make drug take-back programs easier to conduct, but it will
be at least 1-2 years before that is done.  I don’t mean to degrade the DEA. 
When we started working on this ~ 5 years ago, we met road block after road
block.  The DEA is much better now as this problem has grown and they’ve become
more aware.  <o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>We’d be happy to complete the
survey.<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<div>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Jeanie Jaramillo, PharmD<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Managing Director, Texas Panhandle Poison Center<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Assistant Professor, Texas Tech UHSC School of Pharmacy<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>1501 S. Coulter St.                   <o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Amarillo, TX 79106<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>P: (806) 354-1611<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>C: (806) 672-0833<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>F: (806) 354-1667<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Cisco IP: 30412<o:p></o:p></span></p>

</div>

<p class=MsoNormal><span style='color:#1F497D'><o:p>&nbsp;</o:p></span></p>

<div>

<div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'>

<p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Matthew C. Mireles
[mailto:mirelesmc@earthlink.net] <br>
<b>Sent:</b> Wednesday, August 05, 2009 4:01 PM<br>
<b>To:</b> Jaramillo, Jeanie; Tony Madruga; McKinley, Gena;
pharmwaste@lists.dep.state.fl.us<br>
<b>Cc:</b> john.r.prince@dvault.com; easmith@communityofcompetence.com;
Gressitt Stevan; karen.bartkowiak@dvault.com<br>
<b>Subject:</b> RE: [Pharmwaste] RE: Texas Pharmaceutical Disposal Programs<o:p></o:p></span></p>

</div>

</div>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Jeanie,
many thanks for your input.&nbsp; I just returned from a meeting with DEA folks
in DC.&nbsp; Yes, there many programs that do not involve law enforcement and
might get by with it.&nbsp; the main challenge for these program is to ensure that
no controlled substances are collected and handled.&nbsp;&nbsp; Our research
has indicated that this is almost impossible.<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Invariably
controlled substances are commingled in the return.&nbsp; <o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>The
question is &quot;would the DEA come down on you if you stated that you're not
collecting FCS and they show up in your sample?&quot;&nbsp; Here's an
unofficial statement from the DEA.&nbsp; &quot;They might if they want
to.&quot;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Drug
take-back program is a relatively new movement in the US whereas other
countries have successfully implemented return systems without much problems,
mostly direct return to the pharmacies.&nbsp; Historically, there has been a
great deal of diversion in the US that spans all sector but particularly in our
healthcare system (hosp, clinic) and pharmacy system (retail pharmacy,
etc.).&nbsp; This is the rationale behind the DEA's &quot;closed loop
system&quot; with first registrant and the Controlled Substance Act of
1970.&nbsp; <o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Believe
me, everyone wants to do the right thing but don't put yourself in any risk
with the law.&nbsp; While our group work closely with federal agencies in the
research of unused and expired medicines in the US, we DO NOT work for any
federal or state agency.&nbsp;&nbsp; We are completely independent.&nbsp;&nbsp;
We provide research support (data collection, analysis, reporting, etc.) to
anyone or any group that wants to have the info for any number of reasons
(program eval, monitoring, policy, QC, reliability, community education,
etc.).&nbsp;&nbsp; We help groups do sampling to basically ensure that they are
not collecting FCS when they are not supposed to.&nbsp;&nbsp; And we don't
report any group to the law enforcement or DEA, because we are researchers
only!<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Interestingly,
our data are showing unusual post-market side effects.&nbsp; This is the only
area where our researchers believe it is ethically an obligation for us to
notify the FDA or drug manufacturers.&nbsp; <o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>I'd
like to send your our Annual Survey so your group can be included in our
National Directory.&nbsp; Again, congrats on your tremendous leadership and
work in TX.&nbsp; Let me know how we can help.<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;<o:p></o:p></span></p>

<p style='margin-bottom:12.0pt'><span style='font-size:9.0pt;font-family:"Arial","sans-serif";
color:black'>Matt<br>
<br>
<o:p></o:p></span></p>

<blockquote style='border:none;border-left:solid blue 1.5pt;padding:0in 0in 0in 4.0pt;
margin-left:0in;margin-top:5.0pt;margin-bottom:5.0pt'>

<p class=MsoNormal><span style='font-size:9.0pt;font-family:"Arial","sans-serif";
color:black'>-----Original Message----- <br>
From: &quot;Jaramillo, Jeanie&quot; <br>
Sent: Aug 5, 2009 2:25 PM <br>
To: &quot;Matthew C. Mireles&quot; , Tony Madruga , &quot;McKinley,Gena&quot; ,
pharmwaste@lists.dep.state.fl.us <br>
Cc: john.r.prince@dvault.com, easmith@communityofcompetence.com,
karen.bartkowiak@dvault.com <br>
Subject: RE: [Pharmwaste] RE: Texas Pharmaceutical Disposal Programs <br>
<br>
<br>
<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>I am from the Texas Panhandle
Poison Center which is in Amarillo (not Lubbock).&nbsp; We are having our first
take back program on September 12<sup>th</sup>.&nbsp; Law enforcement is
involved.&nbsp; DEA has been our most significant obstacle, but we are finally
getting there.&nbsp; We’ve also had discussions with the TX State Board of
Pharmacy.&nbsp; It is my belief that there are programs in the State that are
conducted without law enforcement involvement.&nbsp; From my correspondence
with the DEA, they are beginning to “crack down” on these.&nbsp; There are many
groups who do not understand all of the regulations and unfortunately, they are
not summarized in any one place.&nbsp; </span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#1F497D'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<div>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Jeanie Jaramillo, PharmD</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Managing Director, Texas Panhandle Poison Center</span><span
style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Assistant Professor, Texas Tech UHSC School of Pharmacy</span><span
style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>1501 S. Coulter
St.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Amarillo, TX 79106</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>P: (806) 354-1611</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>C: (806) 672-0833</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>F: (806) 354-1667</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Monotype Corsiva";
color:#1F497D'>Cisco IP: 30412</span><span style='color:black'><o:p></o:p></span></p>

</div>

<p class=MsoNormal><span style='color:#1F497D'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<div>

<div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'>

<p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
color:black'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
color:black'> Matthew C. Mireles [mailto:mirelesmc@earthlink.net] <br>
<b>Sent:</b> Wednesday, August 05, 2009 9:44 AM<br>
<b>To:</b> Tony Madruga; McKinley,Gena; 'pharmwaste@lists.dep.state.fl.us'<br>
<b>Cc:</b> john.r.prince@dvault.com; easmith@communityofcompetence.com; Karen
Bartkowiak (karen.bartkowiak@dvault.com)<br>
<b>Subject:</b> Re: [Pharmwaste] RE: Texas Pharmaceutical Disposal Programs</span><span
style='color:black'><o:p></o:p></span></p>

</div>

</div>

<p class=MsoNormal><span style='color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Gena,</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>We
run the </span><em><b><span style='font-size:9.0pt;font-family:"Arial","sans-serif";
color:blue'>National Unused and Expired Medicines Registry</span></b></em><span
style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'> and
conduct an annual survey of all&nbsp; the drug take-back programs in the
US.&nbsp; We publish the survey data in our </span><em><b><span
style='font-size:9.0pt;font-family:"Arial","sans-serif";color:blue'>National
Directory of Drug Take-Back and Disposal Programs</span></b></em><span
style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>.&nbsp;
The Directory lists all the programs in the nation.&nbsp; Please contact me if
you wish to have a copy.</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Our
group is based in Houston, but most of our work in drug return system are in
Maine and CA.&nbsp; We also are consulting with federal agencies in designing a
national drug take back system.</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>There
are a few take-back programs in TX (Plano, Dallas area).&nbsp; One is beginning
in Corpus I believe.&nbsp; All of these are small community-based
programs.&nbsp; In Houston, we ran one pilot study with senior citizens.&nbsp;
One for-profit company in Houston has a mail-back system set up with shipping
kits and an incineration unit in Carthage TX.&nbsp;&nbsp; Another large company
in anticipation for a business venture has purchased a large industrial
incineration facility in Chamber Co.&nbsp;&nbsp; </span><span style='color:
black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Since
we provide technical assistance in designing these programs around the country,
we highly encourage the involvement of law enforcement whenever there's a
possibility of collecting controlled substances.&nbsp; Most of the programs in
TX mentioned above all have law enforcement involvement.&nbsp; </span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>We
also publish a comprehensive </span><em><b><span style='font-size:9.0pt;
font-family:"Arial","sans-serif";color:blue'>manual of procedures</span></b></em><span
style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'> for drug
take back.&nbsp; This manual has been selected as the official reference of
instructions for an upcoming international conference on drug disposal in Maine
(mainebenzo.org).</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>As
far as partnership between city govt and retail pharmacies in TX, we have not
seen this in our survey.&nbsp;&nbsp; CA, OR, and WA use this model for their
take back system.&nbsp; In TX, the most promising initiative and partnership
are coming from the Poison Center (Lubbock, Galveston, etc.)&nbsp; You may want
to join the listserv and get involved right away.&nbsp;&nbsp; My advice for now
is to proceed carefully.&nbsp;&nbsp; The DEA is keeping a close eye on
TX.&nbsp;&nbsp; Our programs are in compliance with DEA regs.</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>I
hope my info is useful.&nbsp; Please contact me if you have questions.&nbsp; By
the way, I worked at UTMB before I move to Houston for grad school.</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Matthew
C. Mireles, PhD, MPH</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>President
and CEO</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Community
Medical Foundation for Patient Safety</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>6300
West Loop South, Suite 288</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>Bellaire,
TX 77401</span><span style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>832-778-7777</span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'><a
href="http://www.communityofcompetence.com">www.communityofcompetence.com</a></span><span
style='color:black'><o:p></o:p></span></p>

<p><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'><br>
<br>
&nbsp;</span><span style='color:black'><o:p></o:p></span></p>

<blockquote style='border:none;border-left:solid blue 1.5pt;padding:0in 0in 0in 4.0pt;
margin-left:0in;margin-top:5.0pt;margin-bottom:5.0pt'>

<p class=MsoNormal><span style='font-size:9.0pt;font-family:"Arial","sans-serif";
color:black'>-----Original Message----- <br>
From: Tony Madruga <br>
Sent: Aug 4, 2009 4:18 PM <br>
To: &quot;McKinley, Gena&quot; , &quot;'pharmwaste@lists.dep.state.fl.us'&quot;
<br>
Cc: &quot;john.r.prince@dvault.com&quot; , &quot;Karen Bartkowiak
(karen.bartkowiak@dvault.com)&quot; <br>
Subject: [Pharmwaste] RE: Texas Pharmaceutical Disposal Programs <br>
<br>
<br>
<br>
</span><span style='color:black'><o:p></o:p></span></p>

<div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Hi Gena,</span><span style='color:black'><o:p></o:p></span></p>

</div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>&nbsp;</span><span style='color:black'><o:p></o:p></span></p>

</div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>I am not aware of any current programs in your area, however we
can provide all of your unattended collection unit needs through our sister
company Take Back Express.com.</span><span style='color:black'><o:p></o:p></span></p>

</div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>&nbsp;</span><span style='color:black'><o:p></o:p></span></p>

</div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>More information can be found at: <a
href="http://www.takebackexpress.com/" target="_blank">http://www.takebackexpress.com</a></span><span
style='color:black'><o:p></o:p></span></p>

</div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>&nbsp;</span><span style='color:black'><o:p></o:p></span></p>

</div>

<div>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Regards,</span><span style='color:black'><o:p></o:p></span></p>

</div>

</div>

<div>

<div>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
color:black'>&nbsp; </span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Tony O. Madruga</span><span style='color:black'><br>
</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>President</span><span style='color:black'><br>
</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:navy'>dVault® Companies, Inc.</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
color:black'><a href="http://www.dvault.com/" target="_blank"
title="http://www.dvault.com"><span style='font-size:8.0pt;font-family:"Arial","sans-serif";
color:black'>www.dvault.com</span></a></span><span style='color:black'><o:p></o:p></span></p>

</div>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
color:black'>&nbsp;</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:7.5pt;font-family:"Arial","sans-serif";
color:black'>voice: 720.895.1908<br>
fax: 720.895.1909</span><span style='color:black'><br>
<br>
</span><span style='font-size:7.5pt;font-family:"Arial","sans-serif";
color:blue'><a href="mailto:tony.madruga@dvault.com" target="_blank"
title="mailto:tony.madruga@dvault.com"><span style='color:black'>tony.madruga@dvault.com</span></a></span><span
style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>&nbsp;<o:p></o:p></span></p>

<p><span style='font-size:7.5pt;font-family:"Arial","sans-serif";color:black'>****&nbsp;dVault®</span><span
style='font-size:10.0pt;font-family:"Arial","sans-serif";color:black'>&nbsp;</span><span
style='font-size:7.5pt;font-family:"Arial","sans-serif";color:black'>
Confidential ****************************************<br>
This email and any files transmitted with it are confidential<br>
and intended solely for the individual or entity to<br>
whom they are addressed.&nbsp; If you have received this email<br>
in error destroy it immediately.<br>
**********************************************************************</span><span
style='color:black'><o:p></o:p></span></p>

</div>

<div id=divRpF115272>

<div class=MsoNormal align=center style='text-align:center'><span
style='font-size:9.0pt;font-family:"Arial","sans-serif";color:black'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='margin-bottom:12.0pt'><b><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif";color:black'>From:</span></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";color:black'>
pharmwaste-bounces@lists.dep.state.fl.us
[pharmwaste-bounces@lists.dep.state.fl.us] On Behalf Of McKinley, Gena
[Gena.McKinley@h-gac.com]<br>
<b>Sent:</b> Tuesday, August 04, 2009 2:01 PM<br>
<b>To:</b> 'pharmwaste@lists.dep.state.fl.us'<br>
<b>Subject:</b> [Pharmwaste] Texas Pharmaceutical Disposal Programs</span><span
style='color:black'><o:p></o:p></span></p>

</div>

<div>

<div>

<p class=MsoNormal><span style='color:black'>Hello!<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>I am in the process of working on
a BMP guide for the management of pharmaceutical waste, and am looking for
example programs in the State of Texas.&nbsp; I am also interested to know if
any pharmacies in the State of Texas have partnered with municipalities in the
collection of pharmaceuticals.&nbsp; Please contact me if you have any information.&nbsp;
<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>Thanks!<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>Gena<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Gena McKinley, MPH</span></b><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Environmental Planner</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Houston-Galveston Area Council</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Tel: 713-993-4529</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Fax: 713-993-4503</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'><a href="http://www.h-gac.com/recycleguide" target="_blank">www.RecycleInfo.org</a>
&nbsp;</span><span style='color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='color:black'>&nbsp;<o:p></o:p></span></p>

</div>

</div>

</blockquote>

</blockquote>

</div>

</body>

</html>